* Signal Pharmaceuticals Inc., of San Diego, appointed Miguel Barbosaas director of virology; Mark Goldman as director, drug discovery andpharmacology; Mark Suto as director of medicinal chemistry; andnamed Bradley Gordon as vice president and chief financial officer.* Biometric Research Institute Inc., of Arlington, Va., appointed LaurieAyres as director, quality systems; David Humbert as manager whowill oversee quality systems for the West Coast; and Frank Dorsey assenior technical adviser.* Arris Pharmaceutical Corp., of South San Francisco, appointed LutzGiebel as director of cytokine biology and James Hauske as director ofcombinatorial chemistry.* Trimeris Inc., of Durham, N.C., named Richard Franco, thecompany's president and CEO, to its board of directors.* BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed ZolaHorovitz to its board of directors.* Boron Biologicals Inc., of Raleigh, N.C., named Karel Base as itsnew director of product development and Tish Brown as manager,quality control and analytical science.* Boron Biologicals Inc., of Raleigh, N.C., named Karel Base as itsnew director of product development and Tish Brown as manager,quality control and analytical science.090294A&A

(c) 1997 American Health Consultants. All rights reserved.

No Comments